G. Emons
Impact in
- Reproductive Medicine top 5%
- Hypothalamic control of reproductive hormones
- Ovarian cancer diagnosis and treatment
- Ovarian function and disorders
- Endometriosis Research and Treatment
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Endometrial and Cervical Cancer Treatments 7
- Uterine Myomas and Treatments 2
- Gynecological conditions and treatments 1
-
- Ovarian cancer diagnosis and treatment 5
- Hypothalamic control of reproductive hormones 3
- Endometriosis Research and Treatment 1
- Co-authors
- Carsten Gründker (3 shared papers)Volker Viereck (3 shared papers)Lars Schlotawa (2 shared papers)K.-D. Schulz (1 shared paper)Karin Kast (1 shared paper)Olaf Ortmann (1 shared paper)S. Seitz (1 shared paper)Martin Hellriegel (1 shared paper)
In The Last Decade
G. Emons
18 papers receiving 304 citations
Peers
Comparison fields: 5 of 33
- Reproductive Medicine 151
- Obstetrics and Gynecology 99
- Genetics 81
- Public Health, Environmental and Occupational Health 64
- Endocrinology, Diabetes and Metabolism 32
Countries citing papers authored by G. Emons
This map shows the geographic impact of G. Emons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Emons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Emons more than expected).
Fields of papers citing papers by G. Emons
This network shows the impact of papers produced by G. Emons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Emons. The network helps show where G. Emons may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Emons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 75 | |
| 2 | 2020 | 41 | |
| 3 | 2002 | 32 | |
| 4 | 2002 | 31 | |
| 5 | 2001 | 30 | |
| 6 | 2004 | 28 | |
| 7 | 2000 | 24 | |
| 8 | 2006 | 16 | |
| 9 | 2012 | 7 | |
| 10 | Docetaxel is effective in the treatment of metastatic endometrial cancer. | 2000 | 7 |
| 11 | 2018 | 7 | |
| 12 | 2018 | 3 | |
| 13 | 2010 | 3 | |
| 14 | 2005 | 2 | |
| 15 | 2009 | 2 | |
| 16 | Arbeitsgemeinschaft Gynäkologische Onkologie. Phase II study of weekly docetaxel in patients with recurrent or metastatic endometrial cancer: AGO Uterus-4 | 2007 | 1 |
| 17 | 2002 | 1 | |
| 18 | 2011 | 1 |
About G. Emons
G. Emons is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Genetics, Pulmonary and Respiratory Medicine and Surgery, having authored 18 papers that have together received 311 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (5 papers), Hypothalamic control of reproductive hormones (3 papers), Uterine Myomas and Treatments (2 papers), Estrogen and related hormone effects (2 papers), Ultrasound Imaging and Elastography (1 paper), Endometriosis Research and Treatment (1 paper) and Gynecological conditions and treatments (1 paper). The work is most often cited by research in Reproductive Medicine (151 citations), Obstetrics and Gynecology (99 citations), Genetics (81 citations), Public Health, Environmental and Occupational Health (64 citations) and Endocrinology, Diabetes and Metabolism (32 citations). G. Emons has collaborated with scholars based in Germany, Austria and Belgium. Frequent co-authors include Carsten Gründker, Volker Viereck, Lars Schlotawa, K.-D. Schulz, Karin Kast, Olaf Ortmann, S. Seitz, Martin Hellriegel, Willi Sauerbrei and H Prömpeler. Their work appears in journals such as European Journal of Endocrinology, Journal of Clinical Oncology, Archives of Gynecology and Obstetrics, Gynecologic Oncology and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.